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ABSTRACT 
The antibiotics of choice for the treatment of typhoid fever in most parts of the world is still
chloramphenicol. Ampicillin and cotrimoxazole have been used in recent years. Selection of
antimicrobials for therapy has been complicated by the emergence of Salmonella typhi strains resistant
to the above mentioned antibiotics. Blood and/or bone marrow cultures of 30 adult patients grew S.
typhi that was resistant to chloramphenicol, ampicillin and cotrimoxazole. However, these strains were
sensitive to cefotaxime, ceftrioxone, aztreonam and ofloxacin. Ofloxacin 400mg twice a day was given
orally to these patients for 14 days. All patients recovered with no untoward side effect. We concluded
that ofloxacin can be used as a drug of choice for typhoid fever, in those adult patients who are infected
with S. typhi resistant to chioramphenicol, ampicillin and cotrimoxazole (JPMA 40: 176, 1990).
INTRODUCTION 
Typhoid fever is an acute and systemic illness. Although the incidence has decreased in the West,
typhoid fever is still endemic in Karachi, as it is in other parts of the world with poor sanitation1-3. The
commonest organism which causes typhoid fever is Salmonella typizi and less so are Salmonella
paratyphi A, Salmonella paratyphi B, and Salmonella paratyphi C4. The diagnosis of typhoid fever is
usually suspected on clinical ground and confirmed on the basis of isolation of the organism from
blood5. In the absence of antimicrobial therapy, blood cultures are positive in over 80% of patients seen
in the first week of illness6. Antimicrobial therapy diminishes possibility of recovery of the causative
agents from blood. In these patients cultures of supplementary site such as bone marrow is a better
source of organism than blood7. The antimicrobial of choice for typhoid fever in most areas of the
world is still chloramphenicol8,9. Ampicillin is also effective in the treatment of typhoid fever10 .
Several studies have demonstrated a slower response rate to ampicillin than chloramphenicol10,11.
Trimethoprim-sulfamcthoxazole has been used in recent years in the treatment of typhoid fever12.
Strains of Salmonella typhi resistant to chloramphenicol have been reported in recent years from
Mexico, Vietnam and India13. Ampicillin is recommended as an alternative to chloramphenicol as
antibiotic therapy for typhoid fever caused by chloramphenicol resistant strains of Salm onella typhi14.
Only occasional strains of Salmonella typlii are known to be resistant to both chloramphenicol and
ampicillin15. Trimethoprim-sulfamethoxazole is the drug of choice for typhoid fever caused by
chloramphenicol or ampicillin resistant strains of Salmonella typhi16. Over a period of three years 3224
patients attended emergency room and consulting clinic of the Aga Khan University Hospital Karachi,
for pyrexia of unknown origin. Blood cultures from all of these patients and bone marrow from
selective patients were collected and sent to Microbiology laboratory of The Aga Khan University
Hospital for culture. Total positive isolated were 13% out of which 3 1.5% were Salmonella species.
Further sub typing of species showed Salmonella typhi in 83%. Antibiotic sensitivities result of these
strains showed that approximately 30% were resistant to ampicillin, chloramphenicol and
cotrimoxazole. We report management of 30 such patients suffering from typhoid fever caused by
Salmonella typhi resistant to the first line antibiotics (chioramphenicol, ampicillin and cotrimoxazole).
The aim of this study was to determine the effectiveness of ofloxacinin the treatment of such patients.
MATERIALS AND METHODS 
Samples of blood and/or bone marrow were collected from 30 patients suspected for typhoid fever.
Each blood sample (4-5 mls) or bone marrow sample (0.5 — 1.Oml) was collected in each of the 2
blood culture bottles containing 45ml of aerobic medium (brain heart infusion brOth) and anaerobic
medium (thioglycolate broth). Bottles were immediately transported to the laboratory and incubated at
37°C for 7 days. Gram stain film was made from each bottle daily for 7 days. All bottles were sub
cultured after 24,48,72 hours and 7th day of incubation on to blood agar and MacConkey's media. Non
lactose fermenting colonies from MacConkey’s plate were biochemically speciated using API 20E*
strips. Serological confirmation was done by type specific sera. Antibiotic sensitivity testing of all
isolates was performed by the method described earlier17. The antibiotic discs used were anipicillin
(10mcg), cotrimoxazole (25mcg), chloramphenicol (30mcg), cefotaxime (3Omcg), aztreonam (30mcg),
ceftrioxone(3Omcg) and ofloxacin (5mg).
RESULTS 
A wide variety of clinical presentations were observed in these 30 patients (Table 1).
The blood and/or bone marro* cultures from all the 30 patients grew S. typhi at varied times after
incubation (Table II).
Approximately 7% of the samples grew typhi on either day 1, 4 or S post incubation. However, 53.3%
and 26.7% of the samples grew S. thphi on day 2 and 3 post incubation, respectiyely. The antibiotic
sensitivity test showed all the isolates of S. typhi were resistant to ampicillin, cotrimox4zole and
chloramphenicol, however they were sensitive to cefotaxime, aztreonam, ceftrioxone and ofloxacin. All
patients were initially treated with the first line antibiotic therapy (ampicillin, cotrinioxazole or
chloramphenicol), Eleven patients were prescribed ampicillin 1gm 8 hourly,? patients’received
cotrimoxazole D.S. 12 hourly and 12 patients were given chloramphenicol 1gm 6 hourly. Treatment
was reviewed after the antibiotic sensitivity results were obtained. All patients were then given
ofloxacin, 400mg twice a day, orally for 10 to 14 days. Temperature of all these patients) settled within
48 to 72 hours after the ofloxacin therapy.
DISCUSSION 
This study clearly shows that most common cause of typhoid fever in Karachi is S. typhi as all the
blood and/or bone marrow cultures grew this organism within 5 days of incubation, with over 50%
showing growth of the organism 4t5 hours of incubation. The drugs of choice in typhoid fever are
chloramphenicol, ampicillin and cotrimoxazole5,13,15. All patients were initially treated with these
antibiotics, but did not respond within 48 hours and in some cases even after 5 days of treatment. This
observation indicated the infection with resistant S. typhi which was confirmed by microbiological
results. At this point ofloxacin was administered to these patients. !n the recent past ofloxacin had been
tested in vitro for its efficacy against S. typhi. The minimum inhibitory concentration (M!C) ranged
from 0.03 to 0.12 mcg16,17.. Similarly the mean MICs of cefotaxime, aztreonam, ceftrioxone for S.
typhi has been shown to be less than 0.97 mcg18. The selection of ofloxacin for our patients was done
because the drug is effective in vitro16, can be administered orally therefore eliminates the cost of
hospitalization and is relatively less expensive than the other newer antibiotics. The recommended dose
of ofloxacin in gram negative systemic infections is 200mg twice a day. As these patients are seriously
ill, theywere given 400mg twice a day. Fever subsided within 72 hours after administration of this
therapy. The treatment was continued for 14 days. No untoward effects were observed. Ofloxacin is a
good drug in S. typhi infection resistant to the first line antibiotics. However this drug should riot be
used in children under 14 years of age and in pregnant women. Further studies with a larger group of
patients are recommended to evaluate the dose and effectiveness of this drug to substantiate our
conclusions.
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